Devyser

Devyser is a provider of diagnostic genetic testing solutions designed for laboratories worldwide. Its test kits combine speed, accuracy, and ease of use to support efficient laboratory workflows and help clinicians make timely diagnostic decisions. The company’s products and integrated software serve a broad range of healthcare applications, including post-transplantation monitoring, oncology, hematology, reproductive health, cystic fibrosis, and cardiovascular disease.

Devyser offers DNA test kits and reagents for applications such as chimerism and graft-rejection monitoring, hereditary cancer testing, thalassemia, fetal RHD screening, transfusion medicine, male infertility, and rapid aneuploidy analysis. Its portfolio includes targeted and next-generation sequencing assays, alongside software for analyzing results in areas such as chimerism, solid-organ transplantation, and blood-group testing. The company also provides genomic laboratory services and accessories, including laboratory consumables and index plates. Devyser supports customers through resources such as technical documents, calculators, educational materials, webinars, and customer support. Its stated goal is to help make personalized healthcare more widely available through practical, sensitive genetic testing.